C4 Therapeutics Inc. (CCCC) NASDAQ

$6.72 (0.19) (-2.75%)

Market Cap: $461M

As of 04/19/24 04:00 PM EDT. Market closed.

(CCCC)

C4 Therapeutics Inc. (CCCC)
NASDAQ

$6.72
(0.19) (-2.75%)

Market Cap: $461M

As of 04/19/24 04:00 PM EDT. Market closed.

Add to Portfolio

c4 therapeutics is an early stage drug discovery company whose mission is to harness targeted protein degradation to develop therapeutics for a broad range of diseases. the centerpiece of our approach is the degronimid® platform, which enables highly selective small molecule binders to target disease causing proteins and facilitate their rapid destruction and clearance from the cell through the ... read more

c4 therapeutics is an early stage drug discovery company whose mission is to harness targeted protein degradation to develop therapeutics for a broad range of diseases. the centerpiece of our approach is the degronimid® platform, which enables highly selective small molecule binders to target disease causing proteins and facilitate their rapid destruction and clearance from the cell through the natural ubiquitin/proteasome system. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
152
Address
.
PRICE CHART FOR C4 THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.90
Previous Close
$6.91
Days Range
$6.54 - $7.15
52 week range
$1.06 - $11.88
Volume
1,725,942
Avg. Volume (30 days)
1,412,812
Market Cap
$461M
Dividend Yield
-
P/E
(3.48)
Shares Outstanding
68,600,669
Open
$6.90
Previous Close
$6.91
Days Range
$6.54 - $7.15
52 week range
$1.06 - $11.88
Volume
1,725,942
Avg. Volume (30 days)
1,412,812
Market Cap
$461M
Dividend Yield
-
P/E
(3.48)
Shares Outstanding
68,600,669
FINANCIAL STATEMENTS FOR C4 THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR C4 THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Hirsch AndrewPresident & CEOFeb 15, 2024 Option Exercise$7.906,56051,824210,741Feb 15, 2024, 06:18 PM
Siegel JolieChief Legal OfficerFeb 13, 2024 Option Exercise$6.531,73511,33024,951Feb 15, 2024, 05:07 PM
Schick KellyChief People OfficerFeb 13, 2024 Option Exercise$6.531,73511,33024,951Feb 15, 2024, 05:05 PM
Fisher StewartChief Scientific OfficerFeb 13, 2024 Option Exercise$6.532,25514,725101,821Feb 15, 2024, 05:04 PM
Boyle Scott NChief Business OfficerFeb 13, 2024 Option Exercise$6.531,73511,33025,030Feb 15, 2024, 05:03 PM
Adams KendraChief Financial OfficerFeb 13, 2024 Option Exercise$6.531,3018,49645,339Feb 15, 2024, 05:02 PM
Dubin GlennDirectorJan 02, 2024 Option Exercise$6.521,68710,99920,717Jan 03, 2024, 04:12 PM
Anderson Kenneth CarlDirectorJan 02, 2024 Option Exercise$6.521,72511,247110,962Jan 03, 2024, 04:11 PM
GROGAN DONNA ROYDirectorJan 02, 2024 Option Exercise$6.522,10813,74421,935Jan 03, 2024, 04:10 PM
Anderson Kenneth CarlDirectorOct 02, 2023 Option Exercise$1.706,61711,249109,237Oct 03, 2023, 04:28 PM
GROGAN DONNA ROYDirectorOct 02, 2023 Option Exercise$1.708,08913,75119,827Oct 03, 2023, 04:26 PM
Hirsch AndrewPresident & CEOAug 30, 2023 Option Exercise$2.932,2056,461113,901Aug 31, 2023, 04:13 PM
Siegel JolieChief Legal OfficerAug 30, 2023 Option Exercise$2.936611,93726,686Aug 31, 2023, 04:12 PM
White LaurenChief Financial OfficerAug 30, 2023 Option Exercise$2.936611,93732,686Aug 31, 2023, 04:11 PM
Schick KellyChief People OfficerAug 30, 2023 Option Exercise$2.936611,93726,686Aug 31, 2023, 04:10 PM
Fisher StewartChief Scientific OfficerAug 30, 2023 Option Exercise$2.936611,937104,076Aug 31, 2023, 04:10 PM
Boyle Scott NChief Business OfficerAug 30, 2023 Option Exercise$2.936611,93726,765Aug 31, 2023, 04:09 PM
Anderson Kenneth CarlDirectorJul 03, 2023 Option Exercise$2.833,97611,252102,620Jul 05, 2023, 04:25 PM
Dubin GlennDirectorJul 03, 2023 Option Exercise$2.833,88711,00012,560Jul 05, 2023, 04:24 PM
GROGAN DONNA ROYDirectorJul 03, 2023 Option Exercise$2.834,85813,74811,738Jul 05, 2023, 04:23 PM
Anderson Kenneth CarlDirectorApr 03, 2023 Option Exercise$3.203,51611,25198,644Apr 04, 2023, 04:19 PM
Koppikar UtpalDirectorFeb 08, 2023 Buy$5.605,66731,7355,667Feb 10, 2023, 04:27 PM
Crystal AdamChief Medical OfficerJan 30, 2023 Option Exercise$7.781,30110,12220,097Feb 01, 2023, 04:11 PM
White LaurenChief Financial OfficerJan 30, 2023 Option Exercise$7.781,30110,1225,097Feb 01, 2023, 04:10 PM
Boyle Scott NChief Business OfficerJan 30, 2023 Option Exercise$7.781,2229,5075,176Feb 01, 2023, 04:10 PM
Hirsch AndrewPresident & CEOJan 30, 2023 Option Exercise$7.784,31933,60227,006Feb 01, 2023, 04:09 PM
Schick KellyChief People OfficerJan 30, 2023 Option Exercise$7.781,30110,1225,097Feb 01, 2023, 04:09 PM
Siegel JolieChief Legal OfficerJan 30, 2023 Option Exercise$7.781,30110,1225,097Feb 01, 2023, 04:09 PM
Fisher StewartChief Scientific OfficerJan 30, 2023 Option Exercise$7.781,30110,12276,487Feb 01, 2023, 04:08 PM
Anderson Kenneth CarlDirectorJan 06, 2023 Option Exercise$3.907122,77795,128Jan 06, 2023, 04:55 PM
Anderson Kenneth CarlDirectorJan 03, 2023 Option Exercise$6.381,56810,00494,416Jan 04, 2023, 04:17 PM
GROGAN DONNA ROYDirectorJan 03, 2023 Option Exercise$6.381,76311,2482,582Jan 04, 2023, 04:17 PM
GROGAN DONNA ROYDirectorOct 03, 2022 Option Exercise$8.698197,117819Oct 04, 2022, 06:06 PM
Dubin GlennDirectorOct 03, 2022 Option Exercise$8.691,26510,9933,510Oct 04, 2022, 06:06 PM
Anderson Kenneth CarlDirectorOct 03, 2022 Option Exercise$8.691,1509,99392,848Oct 04, 2022, 06:05 PM
Anderson Kenneth CarlDirectorOct 03, 2022 Option Exercise$3.907122,77991,698Oct 04, 2022, 06:05 PM
Anderson Kenneth CarlDirectorJul 15, 2022 Option Exercise$3.901,4245,55690,986Jul 18, 2022, 05:18 PM
Dubin GlennDirectorJul 01, 2022 Option Exercise$8.031,37211,0172,245Jul 05, 2022, 04:12 PM
Anderson Kenneth CarlDirectorJul 01, 2022 Option Exercise$8.031,24610,00589,562Jul 05, 2022, 04:11 PM
Siegel JolieChief Legal OfficerMay 26, 2022 Option Exercise$7.011,1027,7252,648Jun 14, 2022, 04:45 PM
Hirsch AndrewPresident & CEOMay 26, 2022 Option Exercise$7.013,67525,76218,825Jun 14, 2022, 04:45 PM
Fisher StewartChief Scientific OfficerMay 26, 2022 Option Exercise$7.011,1027,72574,038Jun 14, 2022, 04:45 PM
White LaurenChief Financial OfficerMay 26, 2022 Option Exercise$7.011,1027,7252,648Jun 14, 2022, 04:45 PM
Schick KellyChief People OfficerMay 26, 2022 Option Exercise$7.011,1027,7252,648Jun 14, 2022, 04:45 PM
Crystal AdamChief Medical OfficerMay 26, 2022 Option Exercise$7.011,1027,72517,648Jun 14, 2022, 04:45 PM
Boyle Scott NChief Business OfficerMay 26, 2022 Option Exercise$7.011,1027,7252,648Jun 14, 2022, 04:45 PM
Fisher StewartChief Scientific OfficerApr 12, 2022 Option Exercise$4.8828,084137,12071,390Apr 12, 2022, 08:41 PM
Hirsch AndrewPresident & CEOApr 12, 2022 Buy$8.4010,00084,00010,000Apr 12, 2022, 04:05 PM
Dubin GlennDirectorApr 04, 2022 Option Exercise$26.4637910,028873Apr 05, 2022, 04:27 PM
COHEN ALAIN JDirectorApr 04, 2022 Option Exercise$26.4638810,266928Apr 05, 2022, 04:26 PM
Anderson Kenneth CarlDirectorApr 04, 2022 Option Exercise$26.463419,02388,316Apr 05, 2022, 04:25 PM
Anderson Kenneth CarlDirectorJan 26, 2022 Option Exercise$3.902,1378,33887,975Jan 26, 2022, 05:26 PM
Salter MalcolmDirectorJan 04, 2022 Option Exercise$31.5842813,51611,380Jan 18, 2022, 04:30 PM
Dubin GlennDirectorJan 04, 2022 Option Exercise$31.581996,284494Jan 18, 2022, 04:30 PM
COHEN MARC ADirectorJan 04, 2022 Option Exercise$31.5865720,7481,118Jan 18, 2022, 04:30 PM
COHEN ALAIN JDirectorJan 04, 2022 Option Exercise$31.5831810,042540Jan 18, 2022, 04:30 PM
Anderson Kenneth CarlDirectorJan 04, 2022 Option Exercise$31.582788,77985,838Jan 18, 2022, 04:30 PM
Crystal AdamChief Medical OfficerJan 04, 2022 Option Exercise$6.4915,00097,35030,000Jan 05, 2022, 04:30 PM
Crystal AdamChief Medical OfficerJan 04, 2022 Sale$31.6615,000474,96816,054Jan 05, 2022, 04:30 PM
Crystal AdamChief Medical OfficerDec 22, 2021 Option Exercise$6.495,00032,45015,000Dec 23, 2021, 04:10 PM
Salter MalcolmDirectorDec 17, 2021 Sale$30.2575522,83910,952Dec 17, 2021, 04:28 PM
Fisher StewartChief Scientific OfficerDec 08, 2021 Option Exercise$3.5520,56273,00043,306Dec 10, 2021, 04:30 PM
Salter MalcolmDirectorNov 19, 2021 Sale$40.1175530,28311,707Nov 19, 2021, 04:30 PM
Salter MalcolmDirectorOct 15, 2021 Sale$44.9475533,93012,462Oct 15, 2021, 04:36 PM
Crystal AdamChief Medical OfficerOct 08, 2021 Option Exercise$6.4910,00064,90010,000Oct 12, 2021, 04:30 PM
Salter MalcolmDirectorOct 04, 2021 Option Exercise$44.9930013,49713,217Oct 05, 2021, 04:56 PM
Dubin GlennDirectorOct 04, 2021 Option Exercise$44.991386,209295Oct 05, 2021, 04:55 PM
COHEN MARC ADirectorOct 04, 2021 Option Exercise$44.9946120,740461Oct 05, 2021, 04:55 PM
COHEN ALAIN JDirectorOct 04, 2021 Option Exercise$44.992229,988222Oct 05, 2021, 04:54 PM
Anderson Kenneth CarlDirectorOct 04, 2021 Option Exercise$44.991948,72885,560Oct 05, 2021, 04:53 PM
Crystal AdamChief Medical OfficerOct 01, 2021 Option Exercise$4.9815,00074,70015,000Oct 05, 2021, 04:53 PM
Crystal AdamChief Medical OfficerOct 01, 2021 Sale$45.4315,000681,43813,288Oct 05, 2021, 04:53 PM
Prokupets ElenaDirectorSep 27, 2021 Sale$50.041,31165,604503,126Sep 29, 2021, 06:33 PM
Prokupets ElenaDirectorSep 27, 2021 Sale$50.0453926,96931,681Sep 29, 2021, 06:33 PM
Prokupets ElenaDirectorSep 22, 2021 Sale$50.103,544177,55439,492Sep 24, 2021, 04:51 PM
Prokupets ElenaDirectorSep 24, 2021 Sale$50.102,115105,964504,437Sep 24, 2021, 04:51 PM
Prokupets ElenaDirectorSep 24, 2021 Sale$50.1190045,10132,220Sep 24, 2021, 04:51 PM
Prokupets ElenaDirectorSep 23, 2021 Sale$50.4112,808645,628507,559Sep 24, 2021, 04:51 PM
Prokupets ElenaDirectorSep 23, 2021 Sale$50.406,372321,14433,566Sep 24, 2021, 04:51 PM
Prokupets ElenaDirectorSep 22, 2021 Sale$50.097,004350,860519,360Sep 24, 2021, 04:51 PM
Prokupets ElenaDirectorSep 21, 2021 Sale$50.145,333267,410526,364Sep 21, 2021, 07:26 PM
Prokupets ElenaDirectorSep 21, 2021 Sale$50.134,988250,05143,036Sep 21, 2021, 07:26 PM
Prokupets ElenaDirectorSep 17, 2021 Sale$50.055,688284,687531,697Sep 21, 2021, 07:26 PM
Prokupets ElenaDirectorSep 17, 2021 Sale$50.045,152257,80848,024Sep 21, 2021, 07:26 PM
Salter MalcolmDirectorSep 17, 2021 Sale$49.8975537,66712,917Sep 21, 2021, 07:25 PM
Prokupets ElenaDirectorSep 16, 2021 Sale$48.6426,1531,271,982510,731Sep 16, 2021, 07:31 PM
Prokupets ElenaDirectorSep 16, 2021 Sale$50.0134617,30353,176Sep 16, 2021, 07:31 PM
Prokupets ElenaDirectorSep 15, 2021 Sale$48.9724,1931,184,690563,538Sep 16, 2021, 07:31 PM
Prokupets ElenaDirectorSep 15, 2021 Sale$48.7130,0001,461,20453,522Sep 16, 2021, 07:31 PM
Prokupets ElenaDirectorSep 14, 2021 Sale$50.0349224,614587,731Sep 16, 2021, 07:31 PM
Prokupets ElenaDirectorSep 14, 2021 Sale$50.0149224,60383,522Sep 16, 2021, 07:31 PM
Prokupets ElenaDirectorSep 13, 2021 Sale$50.073,330166,743588,223Sep 14, 2021, 04:10 PM
Prokupets ElenaDirectorSep 13, 2021 Sale$50.073,330166,73084,014Sep 14, 2021, 04:10 PM
Prokupets ElenaDirectorSep 10, 2021 Sale$50.011,32066,010591,553Sep 14, 2021, 04:10 PM
Prokupets ElenaDirectorSep 10, 2021 Sale$50.001,23061,50187,344Sep 14, 2021, 04:10 PM
Siegel JolieChief Legal OfficerSep 10, 2021 Option Exercise$4.9812,50062,25012,500Sep 14, 2021, 04:08 PM
Siegel JolieChief Legal OfficerSep 10, 2021 Sale$50.0012,500625,0000Sep 14, 2021, 04:08 PM
Salter MalcolmDirectorAug 20, 2021 Sale$40.7375530,75113,672Aug 24, 2021, 05:01 PM
Dubin GlennDirectorJul 02, 2021 Option Exercise$39.721576,236157Aug 20, 2021, 04:30 PM
Prokupets ElenaDirectorAug 03, 2021 Sale$45.1614,407650,58788,574Aug 05, 2021, 07:35 PM
Fisher StewartChief Scientific OfficerAug 03, 2021 Sale$45.0117,057767,81222,744Aug 05, 2021, 07:34 PM
Siegel JolieChief Legal OfficerJul 29, 2021 Option Exercise$4.9812,50062,25012,500Aug 02, 2021, 06:49 PM
Siegel JolieChief Legal OfficerJul 29, 2021 Sale$45.0012,500562,5000Aug 02, 2021, 06:49 PM
Prokupets ElenaDirectorJul 29, 2021 Sale$45.0011,336510,168107,238Aug 02, 2021, 06:47 PM
Prokupets ElenaDirectorAug 02, 2021 Sale$45.014,257191,606102,981Aug 02, 2021, 06:47 PM
Fisher StewartChief Scientific OfficerAug 02, 2021 Sale$45.0018,104814,75639,801Aug 02, 2021, 06:46 PM
Fisher StewartChief Scientific OfficerJul 29, 2021 Sale$45.0050,2112,259,63157,905Aug 02, 2021, 06:46 PM
Crystal AdamChief Medical OfficerJul 29, 2021 Option Exercise$4.9815,00074,70015,000Aug 02, 2021, 06:44 PM
Crystal AdamChief Medical OfficerJul 29, 2021 Sale$45.0015,000675,0000Aug 02, 2021, 06:44 PM
Salter MalcolmDirectorJul 16, 2021 Sale$37.3775528,21414,427Jul 19, 2021, 04:30 PM
COHEN MARC ADirectorJul 02, 2021 Option Exercise$39.7252220,7346,641Jul 07, 2021, 04:30 PM
COHEN ALAIN JDirectorJul 02, 2021 Option Exercise$39.722519,970517Jul 07, 2021, 04:30 PM
Anderson Kenneth CarlDirectorJul 02, 2021 Option Exercise$39.722208,73885,366Jul 07, 2021, 04:30 PM
Salter MalcolmDirectorJul 02, 2021 Option Exercise$39.7233913,46515,182Jul 07, 2021, 04:30 PM
Crystal AdamChief Medical OfficerJul 01, 2021 Option Exercise$6.5015,00097,50015,000Jul 06, 2021, 08:00 PM
Crystal AdamChief Medical OfficerJul 01, 2021 Sale$37.9815,000569,6661,700Jul 06, 2021, 08:00 PM
COHEN MARC ADirectorFeb 18, 2021 Option Exercise$2.115361,1315,566Feb 19, 2021, 04:15 PM
Fisher StewartChief Scientific OfficerFeb 03, 2021 Option Exercise$3.258,30026,999108,116Feb 04, 2021, 04:35 PM
Fisher StewartChief Scientific OfficerDec 11, 2020 Option Exercise$3.1814,44445,99899,816Feb 04, 2021, 04:35 PM
Anderson Kenneth CarlDirectorJan 22, 2021 Option Exercise$3.761,5485,81881,924Jan 26, 2021, 04:34 PM
MCKEE WILLIAMChief Financial OfficerOct 06, 2020 Buy$19.005,26399,9975,263Oct 06, 2020, 09:30 PM
COHEN MARC ADirectorOct 06, 2020 Buy$19.005,03095,5705,030Oct 06, 2020, 09:28 PM
Salter MalcolmDirectorOct 06, 2020 Buy$19.001,31524,98515,994Oct 06, 2020, 09:26 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Hirsch AndrewPresident & CEO02/15/202451,824
Siegel JolieChief Legal Officer02/13/202411,330
Schick KellyChief People Officer02/13/202411,330
Fisher StewartChief Scientific Officer02/13/202414,725
Boyle Scott NChief Business Officer02/13/202411,330
Adams KendraChief Financial Officer02/13/20248,496
Dubin GlennDirector01/02/202410,999
Anderson Kenneth CarlDirector01/02/202411,247
GROGAN DONNA ROYDirector01/02/202413,744
Anderson Kenneth CarlDirector10/02/202311,249
GROGAN DONNA ROYDirector10/02/202313,751
Hirsch AndrewPresident & CEO08/30/20236,461
Siegel JolieChief Legal Officer08/30/20231,937
White LaurenChief Financial Officer08/30/20231,937
Schick KellyChief People Officer08/30/20231,937
Fisher StewartChief Scientific Officer08/30/20231,937
Boyle Scott NChief Business Officer08/30/20231,937
Anderson Kenneth CarlDirector07/03/202311,252
Dubin GlennDirector07/03/202311,000
GROGAN DONNA ROYDirector07/03/202313,748
Anderson Kenneth CarlDirector04/03/202311,251
Koppikar UtpalDirector02/08/202331,735
Crystal AdamChief Medical Officer01/30/202310,122
White LaurenChief Financial Officer01/30/202310,122
Boyle Scott NChief Business Officer01/30/20239,507
Hirsch AndrewPresident & CEO01/30/202333,602
Schick KellyChief People Officer01/30/202310,122
Siegel JolieChief Legal Officer01/30/202310,122
Fisher StewartChief Scientific Officer01/30/202310,122
Anderson Kenneth CarlDirector01/06/20232,777
Anderson Kenneth CarlDirector01/03/202310,004
GROGAN DONNA ROYDirector01/03/202311,248
GROGAN DONNA ROYDirector10/03/20227,117
Dubin GlennDirector10/03/202210,993
Anderson Kenneth CarlDirector10/03/20229,993
Anderson Kenneth CarlDirector10/03/20222,779
Anderson Kenneth CarlDirector07/15/20225,556
Dubin GlennDirector07/01/202211,017
Anderson Kenneth CarlDirector07/01/202210,005
Siegel JolieChief Legal Officer05/26/20227,725
Hirsch AndrewPresident & CEO05/26/202225,762
Fisher StewartChief Scientific Officer05/26/20227,725
White LaurenChief Financial Officer05/26/20227,725
Schick KellyChief People Officer05/26/20227,725
Crystal AdamChief Medical Officer05/26/20227,725
Boyle Scott NChief Business Officer05/26/20227,725
Fisher StewartChief Scientific Officer04/12/2022137,120
Hirsch AndrewPresident & CEO04/12/202284,000
Dubin GlennDirector04/04/202210,028
COHEN ALAIN JDirector04/04/202210,266
Anderson Kenneth CarlDirector04/04/20229,023
Anderson Kenneth CarlDirector01/26/20228,338
Salter MalcolmDirector01/04/202213,516
Dubin GlennDirector01/04/20226,284
COHEN MARC ADirector01/04/202220,748
COHEN ALAIN JDirector01/04/202210,042
Anderson Kenneth CarlDirector01/04/20228,779
Crystal AdamChief Medical Officer01/04/202297,350
Crystal AdamChief Medical Officer01/04/2022474,968
Crystal AdamChief Medical Officer12/22/202132,450
Salter MalcolmDirector12/17/202122,839
Fisher StewartChief Scientific Officer12/08/202173,000
Salter MalcolmDirector11/19/202130,283
Salter MalcolmDirector10/15/202133,930
Crystal AdamChief Medical Officer10/08/202164,900
Salter MalcolmDirector10/04/202113,497
Dubin GlennDirector10/04/20216,209
COHEN MARC ADirector10/04/202120,740
COHEN ALAIN JDirector10/04/20219,988
Anderson Kenneth CarlDirector10/04/20218,728
Crystal AdamChief Medical Officer10/01/202174,700
Crystal AdamChief Medical Officer10/01/2021681,438
Prokupets ElenaDirector09/27/202165,604
Prokupets ElenaDirector09/27/202126,969
Prokupets ElenaDirector09/22/2021177,554
Prokupets ElenaDirector09/24/2021105,964
Prokupets ElenaDirector09/24/202145,101
Prokupets ElenaDirector09/23/2021645,628
Prokupets ElenaDirector09/23/2021321,144
Prokupets ElenaDirector09/22/2021350,860
Prokupets ElenaDirector09/21/2021267,410
Prokupets ElenaDirector09/21/2021250,051
Prokupets ElenaDirector09/17/2021284,687
Prokupets ElenaDirector09/17/2021257,808
Salter MalcolmDirector09/17/202137,667
Prokupets ElenaDirector09/16/20211,271,982
Prokupets ElenaDirector09/16/202117,303
Prokupets ElenaDirector09/15/20211,184,690
Prokupets ElenaDirector09/15/20211,461,204
Prokupets ElenaDirector09/14/202124,614
Prokupets ElenaDirector09/14/202124,603
Prokupets ElenaDirector09/13/2021166,743
Prokupets ElenaDirector09/13/2021166,730
Prokupets ElenaDirector09/10/202166,010
Prokupets ElenaDirector09/10/202161,501
Siegel JolieChief Legal Officer09/10/202162,250
Siegel JolieChief Legal Officer09/10/2021625,000
Salter MalcolmDirector08/20/202130,751
Dubin GlennDirector07/02/20216,236
Prokupets ElenaDirector08/03/2021650,587
Fisher StewartChief Scientific Officer08/03/2021767,812
Siegel JolieChief Legal Officer07/29/202162,250
Siegel JolieChief Legal Officer07/29/2021562,500
Prokupets ElenaDirector07/29/2021510,168
Prokupets ElenaDirector08/02/2021191,606
Fisher StewartChief Scientific Officer08/02/2021814,756
Fisher StewartChief Scientific Officer07/29/20212,259,631
Crystal AdamChief Medical Officer07/29/202174,700
Crystal AdamChief Medical Officer07/29/2021675,000
Salter MalcolmDirector07/16/202128,214
COHEN MARC ADirector07/02/202120,734
COHEN ALAIN JDirector07/02/20219,970
Anderson Kenneth CarlDirector07/02/20218,738
Salter MalcolmDirector07/02/202113,465
Crystal AdamChief Medical Officer07/01/202197,500
Crystal AdamChief Medical Officer07/01/2021569,666
COHEN MARC ADirector02/18/20211,131
Fisher StewartChief Scientific Officer02/03/202126,999
Fisher StewartChief Scientific Officer12/11/202045,998
Anderson Kenneth CarlDirector01/22/20215,818
MCKEE WILLIAMChief Financial Officer10/06/202099,997
COHEN MARC ADirector10/06/202095,570
Salter MalcolmDirector10/06/202024,985
Load More Insider Transactions
FUNDS WITH A POSITION IN C4 THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RA CAPITAL MANAGEMENT, L.P.4,878,0000.43%NewOther
BLACKROCK INC.1,803,4330.00026%-13.93%Other
BALYASNY ASSET MANAGEMENT L.P.1,704,2690.02%NewEvent Driven
GEODE CAPITAL MANAGEMENT, LLC482,2880.00029%5.8%Other
RENAISSANCE TECHNOLOGIES LLC424,7000.00371%18.64%Other
D. E. SHAW & CO., INC.243,6380.0012%-43.88%Other
AQR CAPITAL MANAGEMENT LLC148,6100.00158%-86.4%Other
ROYCE & ASSOCIATES LP42,5540.00222%NewValue
CHANGE IN SHARES OUTSTANDING FOR C4 THERAPEUTICS INC
STOCK BUYBACKS FOR C4 THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
4.14%
1Q
12/31/2023
06/30/2023
4.46%
2Q
12/31/2023
03/31/2023
4.53%
3Q
12/31/2023
12/31/2022
4.67%
4Q
12/31/2023
09/30/2022
4.76%
5Q
12/31/2023
06/30/2022
4.97%
6Q
12/31/2023
03/31/2022
5.16%
7Q
12/31/2023
12/31/2021
5.29%
8Q
12/31/2023
09/30/2021
5.69%
9Q
12/31/2023
06/30/2021
16.87%
10Q
12/31/2023
03/31/2021
18.96%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
4.14%
1Q
06/30/2023
4.46%
2Q
03/31/2023
4.53%
3Q
12/31/2022
4.67%
4Q
09/30/2022
4.76%
5Q
06/30/2022
4.97%
6Q
03/31/2022
5.16%
7Q
12/31/2021
5.29%
8Q
09/30/2021
5.69%
9Q
06/30/2021
16.87%
10Q
03/31/2021
18.96%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR C4 THERAPEUTICS INC
LOADING...